packageEribulin

eribulin

Extends from Pharmacolibrary.Interfaces.PartialSubstance (Identity and physicochemical constants of one drug (Drugs.Substances)).

Information

Eribulin is an anticancer medicine used to treat breast cancer and a type of soft-tissue sarcoma called liposarcoma. It is authorised in the European Union and used as an antineoplastic agent for these cancers.

Summary written by glm-5.3-flash from Wikidata Q408717 and the WHO ATC classification and the EMA medicines list; not checked by a person.

name:eribulin
ATC codes:L01XX41
DrugBank:DB08871
PubChem CID:73425383
ChEBI:63587
Wikidata:Q408717
formula:C40H59NO11
molar mass:729.908 g/mol (PubChem CID 73425383)
logP:1.1 (Drugs.Common 25.09, not verified)

Parameters

TypeNameDefaultDescription
Stringname (from PartialSubstance)""INN / common name
String[:]atcCodes (from PartialSubstance)fill("", 0)all WHO ATC codes of the drug
StringdrugbankId (from PartialSubstance)""e.g. DB00758
StringpubchemCid (from PartialSubstance)""PubChem compound id
StringchebiId (from PartialSubstance)""ChEBI id (number)
StringwikidataId (from PartialSubstance)""e.g. Q410238
Stringformula (from PartialSubstance)""molecular formula
Modelica.Units.SI.MolarMassM (from PartialSubstance)0molar mass; 0 = unknown
ReallogP (from PartialSubstance)Modelica.Constants.infoctanol-water partition coefficient (log10); inf = unknown